EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut–Heart Axis and Infective Endocarditis: How Microbiota Dysbiosis Shapes Cardiovascular Risk and Infection Susceptibility

Livia Moffa, Claudio Tana iD, Tiziana Meschi, Carmine Siniscalchi, Nicoletta Cerundolo, Claudio Ucciferri iD, Jacopo Vecchiet iD, Katia Falasca iD

Journal of Clinical Medicine · 12.01.2026 · 15 (2) · 597

DOI: 10.3390/jcm15020597 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.01.2026. Verfasst von Livia Moffa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinics of Infectious Diseases, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut–heart axis represents a key determinant of cardiovascular (CV) system health. Emerging evidence indicates that intestinal dysbiosis can induce a state of chronic systemic inflammation which, together with mechanisms of endothelial dysfunction, increases the risk of CV diseases. Infective endocarditis (IE) exemplifies this concept, as microbiota alterations may promote bacterial translocation from the gut into the bloodstream, leading to colonization of cardiac valves and subsequent endocardial infection. This narrative review examines current scientific evidence on the relationship between the gut microbiota and CV diseases, with a particular focus on IE. We also summarize the mechanisms underlying impaired intestinal barrier integrity, immune activation, and the production of microbiota-derived metabolites that contribute to CV disease. Special attention is given to potential preventive and therapeutic strategies, including microbiota modulation, targeted antibiotic management, and personalized medicine approaches tailored to individual patient profiles.

Schlagwörter

Stichwörter der Autor:innen

cardiovascular diseasedysbiosisgut–heart axisinfective endocarditismicrobiotamicrobiota-derived metabolites

Autor:innen und Institutionen

  • Clinics of Infectious Diseases, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.
  • Internal Medicine Unit, Eastern Hospital, ASL Taranto, 74024 Manduria, Italy.
  • Internal Medicine Department, Parma University Hospital, 43126 Parma, Italy.

ORCID-Profile: Claudio Tana, Claudio Ucciferri, Jacopo Vecchiet, Katia Falasca

Zitieren

APA

Moffa, L., Tana, C., Meschi, T., Siniscalchi, C., Cerundolo, N., Ucciferri, C., Vecchiet, J., & Falasca, K. (2026). Gut–Heart Axis and Infective Endocarditis: How Microbiota Dysbiosis Shapes Cardiovascular Risk and Infection Susceptibility. Journal of Clinical Medicine, 15(2), 597. https://doi.org/10.3390/jcm15020597

Vancouver

Moffa L, Tana C, Meschi T, Siniscalchi C, Cerundolo N, Ucciferri C, et al. Gut–Heart Axis and Infective Endocarditis: How Microbiota Dysbiosis Shapes Cardiovascular Risk and Infection Susceptibility. Journal of Clinical Medicine. 2026;15(2):597. doi:10.3390/jcm15020597

BibTeX
@article{Moffa2026,
  author = {Moffa, Livia and Tana, Claudio and Meschi, Tiziana and Siniscalchi, Carmine and Cerundolo, Nicoletta and Ucciferri, Claudio and Vecchiet, Jacopo and Falasca, Katia},
  title = {Gut–Heart Axis and Infective Endocarditis: How Microbiota Dysbiosis Shapes Cardiovascular Risk and Infection Susceptibility},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {597},
  doi = {10.3390/jcm15020597}
}
Kostenlos starten →